Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ADAP - Adaptimmune EPS beats by $0.21 beats on revenue


ADAP - Adaptimmune EPS beats by $0.21 beats on revenue

Adaptimmune (NASDAQ:ADAP): Q3 GAAP EPS of -$0.05 beats by $0.21. Revenue of $1.2M (+0.8% Y/Y) beats by $0.26M. Press Release Financial Guidance: The Company believes that its existing cash, cash equivalents and marketable securities, together with the upfront and exclusivity payments under the Strategic Collaboration and License Agreement with Genentech, will fund the Company’s current operations into early 2024

For further details see:

Adaptimmune EPS beats by $0.21, beats on revenue
Stock Information

Company Name: Adaptimmune Therapeutics plc
Stock Symbol: ADAP
Market: NASDAQ
Website: adaptimmune.com

Menu

ADAP ADAP Quote ADAP Short ADAP News ADAP Articles ADAP Message Board
Get ADAP Alerts

News, Short Squeeze, Breakout and More Instantly...